Novozymes A/S
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Novozymes A/S generated cash of $4,152,000,000, which is more than the previous year. Cash used in financing activities reached the amount of -$1,889,000,000 last year. Net change in cash is therefore $75,000,000.
Cash Flow
| 2014 | 4.52B | -310M | -2.70B |
|---|---|---|---|
| 2015 | 3.33B | -1.25B | -3.68B |
| 2016 | 3.84B | -1.34B | -2.48B |
| 2017 | 4.06B | -1.66B | -2.81B |
| 2018 | 3.67B | -1.39B | -2.16B |
| 2019 | 3.19B | -561M | -2.64B |
| 2020 | 4.35B | -1.52B | -2.31B |
| 2021 | 4.06B | -2.74B | -1.58B |
| 2022 | 4.00B | -2.67B | -1.25B |
| 2023 | 4.15B | -2.13B | -1.88B |
NVZMY Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 1.04B | 963M | 1.18B | 711M | 723M | 632M | 805M | 796M | 2.45B | 942M |
Operating activities | ||||||||||
Net income | 3.03B | 3.68B | 3.14B | 2.82B | 3.15B | 3.22B | 3.12B | 3.05B | 2.82B | 2.52B |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 1.38B | 1.45B | 1.41B | 1.26B | 1.18B | 1.01B | 1.04B | 974M | 953M | 866M |
Stock-based compensation expense | 151M | 127M | 78M | 54M | 51M | 89M | 127M | 126M | 121M | 107M |
| Deferred income tax benefit | 151M | 127M | 78M | 54M | 51M | 89M | 127M | 126M | 121M | 107M |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | -177M | -330M | -574M | 395M | -238M | -361M | -96M | 13M | -311M | 231M |
Inventories | 138M | -787M | -556M | 181M | 218M | -234M | -224M | -199M | -60M | -186M |
Accounts payable | 177M | 534M | 518M | -265M | -124M | -265M | 0 | 0 | 0 | 0 |
Cash generated by operating activities | 4.15B | 4.00B | 4.06B | 4.35B | 3.19B | 3.67B | 4.06B | 3.84B | 3.33B | 4.52B |
Investing activities | ||||||||||
Purchases Of Investments | 0 | 0 | 0 | 0 | 0 | -4M | -7M | -15M | 0 | -14M |
Investments In Property Plant And Equipment | -1.85B | -2.89B | -1.24B | -940M | -997M | -1.39B | -1.69B | -1.21B | -1.03B | -723M |
Acquisitions Net | -81M | 190M | -1.63B | -588M | 430M | -4M | 4M | -146M | -242M | -14M |
Cash generated by investing activities | -2.13B | -2.67B | -2.74B | -1.52B | -561M | -1.39B | -1.66B | -1.34B | -1.25B | -310M |
Financing activities | ||||||||||
Common Stock Issued | 167M | 164M | 309M | 508M | 75M | 172M | 179M | 69M | 126M | 85M |
Payments for dividends | -2.85B | -1.52B | -1.46B | -1.48B | -1.43B | -1.31B | -1.19B | -1.06B | -925M | -787M |
Repurchases of common stock | 0 | -500M | -1.5B | -1.5B | -2B | -2B | -2B | -2B | -2B | -2B |
Repayments of term debt | 865M | 418M | -1.28B | -434M | 779M | -1.11B | 460M | -773M | -484M | 0 |
Cash used in financing activities | -1.88B | -1.25B | -1.58B | -2.31B | -2.64B | -2.16B | -2.81B | -2.48B | -3.68B | -2.70B |
Net Change In Cash | 75M | 78M | -218M | 470M | -12M | 91M | -442M | 9M | -1.65B | 1.51B |
Cash at end of period | 1.11B | 1.04B | 963M | 1.18B | 711M | 723M | 363M | 805M | 796M | 2.45B |